Dataset Overview

Definition:Mammography X-Ray Imaging Datasetis provided byChangsha Langhui Information Technology Co., Ltd.A Large-Scale X-Ray Imaging Database Built. Based on 300,000 Cases. Final settlement is based on the de-publiced count of accidental exports/Studies (diagnostic administrative reports are still accounted with the same example). Accomplishable X-Ray (Mammography) check as the subject, using the DICOM standard Raw Data Format, to maintain complete sequence information, spatial geometry parameters and Metadata. Overing more than 10 cooperation cases, from multi-center sources, with strict Quality control; capable for mediamaging AI model training and assessed-diagnosis capacity building.

Dataset NameMammography X-Ray Imaging Dataset
Total Data Volume300,000 Cases (counted toward the total X-ray volume of 200,000 cases)。Final settlement is based on the de-duplicated count of accepted bilateral examinations / Studies (diagnostic unilateral supplementary views are still counted within the same examination)。(Bilateral Examination / Study Level (diagnostic unilateral supplementary views are still counted within the same examination))
Imaging ModalityX-Ray (Mammography)
Scan ProtocolDouble-sided CC; double-sided MLO; diagnostic complementary view; digital mammography/DBT (if any); synthesis of 2D maps separated from original projection. The protocol name must be consistent with the actual document, scope, period, view or sequence.
Raw Data FormatDe-identified raw DICOM with full hierarchy and metadata preserved
Core Conditions (P0)Breast masses, suspicious calcifications, focal / global asymmetry, architectural distortion, breast cancer, etc.
Extended Conditions (P1)Screening negative
Source InstitutionIt is recommended to cover 10–20 institutions, with a minimum of 10 in principle and no upper limit;The specific number of partner Grade-A tertiary hospitals is adjusted flexibly according to the delivered data volume
Quality Control StandardsKappa ≥ 0.75, five-tier L1–L5 quality grading
Use CasesAI model training, assisted diagnosis, radiomics research, algorithm validation

Disease Distribution Overview

100% 75% 50% 25% 0% 77% Breast swollen. 62% Suspicious calcification 23% The cooker/the whole... 88% Structural Distortion 94% Breast Cancer 44% DCIS Image... 90% Good calcium/Lyon... 23% Breast density

Delivery Specifications and Field Requirements

The dataset strictly follows unified delivery index requirements to ensure data quality and traceability。

Delivery & Counting:One row corresponds to one bilateral examination / Study (diagnostic unilateral supplementary views are still counted within the same examination);Multiple sequences, phases, reconstructions, views or repeated exports within the same exam may not be counted separately。

Composition of Positive Cases:Abnormal / positive examinations as the main body;Screening-negative cases must be established as an independent control group and stratified by BI-RADS and follow-up status, with the proportion fixed in the purchase order。Findings such as "suspected", "considered", "cannot be excluded" and "post-treatment changes" must be retained separately from pathologically confirmed diagnoses and must not be forcibly merged into a definite diagnosis。

Coverage:Standard bilateral CC and MLO views as the main body;Supplementary compression / magnification views, implant views and tomosynthesis must be labeled in separate layers。Positive, negative or disease labels are generated only for structures that are actually within the diagnostic field of view and whose image quality supports evaluation。

Raw Data Requirements:de-identified original DICOM or equipment is a non-destructive digital image, with exposure parameters, pixel spacing, position/view, plant model and original/processed state; film flipping, report amplification and social software compression are not allowed to replace. Amputation, film photographs, report PDF or key frame puzzles are not allowed to replace the agreed original image/video/slice.

Field Group Coverage:Batch source and location, anonymized patient information, exam primary key, modality and body part, protocol and device, specialized fields, file hierarchy, report text, diagnostic labels, clinical context, related fields, quality and disposition

Structured Text:At minimum, retain the exam name, exam findings, diagnostic conclusion/impression, primary diagnosis, fine-grained labels, and negative and uncertain semantics;When original reports are available, they must be linked case by case。

Data Volume Growth Trend

2021 2022 2023 2024 2025 2026 1000% 100%

2026 Frontier AI Research Progress

Domain Review:The X-ray series of AIs from 2025 to 2026 entered the basic model age, and large-scale pre-training models made breakthroughs in multi-mission broad-based and small sample learning. The top journals Nature, Nature Medicine, The Lancet and others published several clinical-level validation studies that facilitated the transition of the X-ray series of AIs from laboratory to clinical deployment.

DeepMind Mammography AI Clinical Validation

Nature, 2025

DeepMind Breast AI achieved a 19 per cent reduction in false positives and a 20 per cent reduction in pseudo negatives in over a million screening cases, which was consistent in the validation of multiple European multi-country centres.

Mammography Screening AI Large-Scale Clinical Deployment

The Lancet Oncology, 2026

The national breast screening study in Sweden showed that AAA-assisted screening had increased cancer detection rates by 13 per cent and that the rate of inter-stage cancer had decreased significantly.

Multi-View Mammography Transformer

IEEE TMI, 2025

Transformer structure based on a double view integration of CC/MLO, with radiologists in BI-RADS classification and breast cancer risk prediction.

Digital Breast Tomosynthesis AI

Radiology, 2026

DBT 3D breast-tectonic synthesis AI detection system, which is 25% higher than traditional 2D molybdenum detection in the meth-memplified population.

Annotation Workflow & Quality Control

1

Image Acquisition & De-identification

Standardized acquisition workflow: complete data is exported directly from the devices, and patient identifiers (PHI) are removed before storage to ensure data compliance。

2

Initial Annotation (Specialist Physician)

Attending physicians annotate case by case against the standard, including lesion localization, morphological description, disease diagnostic labels and specialized indicators。

3

Review (Associate Chief Physician or Above)

Experts with the title of Associate Chief Physician or above review each initial annotation result item by item, correcting erroneous annotations and supplementing missing dimensions to ensure annotation accuracy。

4

Consistency Assessment

10% of samples are randomly selected and independently annotated by 3 physicians to calculate Fleiss' Kappa; below 0.Dimensions scored 75 are flagged for rework。

Quality Acceptance Checklist

Total Volume & Deduplication
Source & Licensing
Raw Data
Technical Integrity
Reports & Labels
Image-Text Source Consistency
Composition of Positive Cases
Core Items
Center Coverage & Distribution Diversity
Physician Sampling Inspection
Quality Benchmark & Independent Sampling Inspection
De-identification

License and Usage Agreement

Academic Research License

For universities and research institutions, supporting academic research related to medical AI。After signing the agreement, a de-identified data subset is provided; the source must be acknowledged:Langhui Technology DataAssetsAPI。

Commercial License

For medical device companies and AI diagnostics companies, supporting medical AI product R&D and medical device registration。Provides full datasets + custom annotation + incremental update services。

Data Compliance Statement

All images come from legally authorized sources; PHI fields are fully de-identified and contain no information that can directly identify an individual, in compliance with the Personal Information Protection Law and the Data Security Law。

Customized services

Supports extended requirements such as adding specific disease types, multimodal annotation expansion, and custom training of AI-assisted diagnostic models。

Quick Facts

Dataset CodeXRAY-MAM
Total Data Volume300,000 Cases (counted toward the total X-ray volume of 200,000 cases)。Final settlement is based on the de-duplicated count of accepted bilateral examinations / Studies (diagnostic unilateral supplementary views are still counted within the same examination)。
Imaging ModalityX-Ray (Mammography)
Source InstitutionPartner Grade-A Tertiary Hospitals
Quality Control StandardsKappa ≥ 0.75
Compliance & LicensingEnd-to-End Compliance

AI Frontier Research

The X-ray series 2025-2026 AI entered the basic model phase, with multi-modular self-monitoring learning performing excellently in a number of benchmark missions, and several top-level journal papers promoted clinical AI diagnostic development.

Latest 2025–2026 Papers
Nature / Nature Medicine-level Research
FDA / NMPA / CE Regulatory Updates